NCT07427199Recruiting
Effect of Digitally Supported Medical Nutrition Therapy on Left Ventricular Ejection Fraction in Patients With ST-Elevation Myocardial Infarction
Effect of Digitally Supported Medical Nutrition Therapy on Left Ventricular Ejection Fraction in Patients With ST-Elevation Myocardial Infarction: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 23 Feb 2026
Brief summary (registry, in English)
This study is designed to investigate the effect of a nutrition program supported by digital content on heart function in patients who have experienced a heart attack with ST-elevation. Participants will receive personalized dietary guidance and digital support materials for three months. The main goal is to determine whether this digital support materials can improve heart pumping function (measured by left ventricular ejection fraction). Participation involves following the dietary program and undergoing heart function measurements at the beginning, after one months and after three months.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 16 Feb 2026
- Start date
- 30 Dec 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Saglik Bilimleri Universitesi
- Diseases
- Coronary artery disease
- NCT number
- NCT07427199
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 30 Dec 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Those who have previously received nutrition education or eating awareness training
Other illness
- Those with malignancy, chronic renal failure or severe systemic disease
- Patients unable to complete the questionnaires due to severe cognitive impairment
Age
- Individuals aged over 65
Other
- Those who did not sign the voluntary consent form
- Weight loss exceeding 5% in the last 3 months
Who the study is looking for
- Individuals aged 19-65 who have fully completed the voluntary consent form
- Being of normal weight (BMI 18.5-24.9 kg/m²) or obese (30-34.99 kg/m²)
- Having suffered a heart attack with ST elevation (STEMI)
- To be enrolled in the study within the first 72 hours after hospital admission
- To be willing to participate in a follow-up period of at least 3 months
Age in the registry: 19 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ondokuz Mayıs Üniversitesi Tıp Fakültesi Hastanesi Coordinator of this site? Confirm its status | Samsun | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.